跳至主要内容
临床试验/IRCT20200529047594N1
IRCT20200529047594N1招募中3 期

Comparison of efficacy & safety of intratracheal Beraksurf with Survanta and Curosurf in preterm newborns with Respiratory distress syndrome (RDS)

Iran University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 day 至 2 days(—)
性别
All

入选标准

  • Parents consent to participate study
  • premature neonates with a gestational age of less than 34 weeks
  • premature neonates with diagnosis of RDS and candidates for surfactant
  • A maximum of 8 hours have elapsed since the birth

排除标准

  • No parents consent to participate study
  • Newborns with congenital heart diseases and other life threatening congenital anomalies.
  • Adverse drug effects

研究者

相似试验